Sex-specific association of fatty acid binding protein 2 and microsomal triacylglycerol transfer protein variants with response to dietary lipid changes in the 3-mo Medi-RIVAGE primary intervention study

American Journal of Clinical Nutrition

Volumn 86, Issue 6, 2007, Pages 1633-1641

  Gastaldi, Marguerite ^a   Dizière, Sophie ^b   Defoort, Catherine ^b   Portugal, Henri ^b   Lairon, Denis ^b   Darmon, Michel ^b   Planells, Richard ^b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b NONE

Author keywords

Dietary fats; FABP2 polymorphism; Fatty acid binding protein 2; Mediterranean diet; Microsomal triacylglycerol transfer protein; MTTP polymorphism; Risk assessment; Serum lipids

Indexed keywords

ALANINE; APOLIPOPROTEIN B; CARRIER PROTEIN; CHOLESTEROL; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 2; ICOSAPENTAENOIC ACID; INSULIN; LINOLENIC ACID; LIPOPROTEIN; MICROSOMAL TRIACYLGLYCEROL TRANSFER PROTEIN; MONOUNSATURATED FATTY ACID; OLEIC ACID; PALMITIC ACID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; THREONINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE MARKER; DNA POLYMORPHISM; FAT INTAKE; FATTY ACID BLOOD LEVEL; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSOME; PROTEIN VARIANT; SEX DIFFERENCE;

EID: 36849022500     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/86.5.1633     Document Type: Article

References (32)

1. Elmadfa I, Freisling H. Fat intake, diet variety and health promotion. Forum Nutr 2005;1-10.
2. Corella D, Ordovas JM. Single nucleotide polymorphisms that influence lipid metabolism: interaction with dietary factors. Annu Rev Nutr 2005;25:341-90.
3. Baier LJ, Sacchettini JC, Knowler WC, et al. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 1995;95:1281-7.
4. Agren JJ, Valve R, Vidgren H, Laakso M, Uusitupa M. Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid-binding protein 2 gene. Arterioscler Thromb Vasc Biol 1998;18:1606-10.
5. Dworatzek PD, Hegele RA, Wolever TM. Postprandial lipemia in subjects with the threonine 54 variant of the fatty acid-binding protein 2 gene is dependent on the type of fat ingested. Am J Clin Nutr 2004;79:1110-7.
6. Wetterau JR, Aggerbeck LP, Bouma ME, et al. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 1992;258:999-1001.
7. Karpe F, Lundahl B, Ehrenborg E, Eriksson P, Hamsten A. A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels. Arterioscler Thromb Vasc Biol 1998;18:756-61.
8. Ledmyr H, McMahon AD, Ehrenborg E, et al. The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of coronary heart disease. Circulation 2004;109:2279-84.
9. Juo SH, Han Z, Smith JD, Colangelo L, Liu K. Common polymorphism in promoter of microsomal triglyceride transfer protein gene influences cholesterol, ApoB, and triglyceride levels in young African American men: results from the coronary artery risk development in young adults (CARDIA) study. Arterioscler Thromb Vasc Biol 2000;20:1316-22.
10. Couture P, Otvos JD, Cupples LA, Wilson PW, Schaefer EJ, Ordovas JM. Absence of association between genetic variation in the promoter of the microsomal triglyceride transfer protein gene and plasma lipoproteins in the Framingham Offspring Study. Atherosclerosis 2000;148:337-43.
11. Stan S, Lambert M, Delvin E, et al. Intestinal fatty acid binding protein and microsomal triglyceride transfer protein polymorphisms in French-Canadian youth. J Lipid Res 2005;46:320-7.
12. Yamada Y, Ando F, Shimokata H. Association of a microsomal triglyceride transfer protein gene polymorphism with blood pressure in Japanese women. Int J Mol Med 2006;17:83-8.
13. Vincent S, Gerber M, Bernard MC, et al. The Medi-RIVAGE study (Mediterranean Diet, Cardiovascular Risks and Gene Polymorphisms): rationale, recruitment, design, dietary intervention and baseline characteristics of participants. Public Health Nutr 2004;7:531-42.
14. Vincent-Baudry S, Defoort C, Gerber M, et al. The Medi-RIVAGE study: reduction of cardiovascular disease risk factors after a 3-mo intervention with a Mediterranean-type diet or a low-fat diet. Am J Clin Nutr 2005;82:964-71.
15. Pihlajamaki J, Rissanen J, Heikkinen S, Karjalainen L, Laakso M. Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 1997;17:1039-44.
16. Lei HH, Coresh J, Shuldiner AR, Boerwinkle E, Brancati FL. Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes 1999;48:1868-72.
17. Galluzzi JR, Cupples LA, Meigs JB, Wilson PW, Schaefer EJ, Ordovas JM. Association of the Ala54-Thr polymorphism in the intestinal fatty acid-binding protein with 2-h postchallenge insulin levels in the Framingham Offspring Study. Diabetes Care 2001;24:1161-6.
18. Tahvanainen E, Molin M, Vainio S, et al. Intestinal fatty acid binding protein polymorphism at codon 54 is not associated with postprandial responses to fat and glucose tolerance tests in healthy young Europeans. Results from EARS II participants. Atherosclerosis 2000;152:317-25.
19. Okada T, Sato NF, Kuromori Y, et al. Thr-encoding allele homozygosity at codon 54 of FABP 2 gene may be associated with impaired delta 6 desaturase activity and reduced plasma arachidonic acid in obese children. J Atheroscler Thromb 2006;13:192-6.
20. Formanack ML, Baier LJ. Variation in the FABP2 promoter affects gene expression: implications for prior association studies. Diabetologia 2004;47:349-51.
21. Storch J, Veerkamp JH, Hsu KT. Similar mechanisms of fatty acid transfer from human anal rodent fatty acid-binding proteins to membranes: liver, intestine, heart muscle, and adipose tissue FABPs. Mol Cell Biochem 2002;239:25-33.
22. Baier LJ, Bogardus C, Sacchettini JC. A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J Biol Chem 1996;271:10892-6.
23. Levy E, Menard D, Delvin E, et al. The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants. J Biol Chem 2001;276:39679-84.
24. Galluzzi JR, Cupples LA, Otvos JD, Wilson PW, Schaefer EJ, Ordovas JM. Association of the A/T54 polymorphism in the intestinal fatty acid binding protein with variations in plasma lipids in the Framingham Offspring Study. Atherosclerosis 2001;159:417-24.
25. Agellon LB, Li L, Luong L, Uwiera RR. Adaptations to the loss of intestinal fatty acid binding protein in mice. Mol Cell Biochem 2006;284:159-66.
26. Xie Y, Newberry EP, Young SG, et al. Compensatory increase in hepatic lipogenesis in mice with conditional intestine-specific Mttp deficiency. J Biol Chem 2006;281:4075-86.
27. Aggarwal D, West KL, Zern TL, Shrestha S, Vergara-Jimenez M, Fernandez ML. JTT-130, a microsomal triglyceride transfer protein (MTP) inhibitor lowers plasma triglycerides and LDL cholesterol concentrations without increasing hepatic triglycerides in guinea pigs. BMC Cardiovasc Disord 2005;5:30.
28. Lundahl B, Hamsten A, Karpe F. Postprandial plasma ApoB-48 levels are influenced by a polymorphism in the promoter of the microsomal triglyceride transfer protein gene. Arterioscler Thromb Vasc Biol 2002;22:289-93.
29. Hagan DL, Kienzle B, Jamil H, Hariharan N. Transcriptional regulation of human and hamster microsomal triglyceride transfer protein genes. Cell type-specific expression and response to metabolic regulators. J Biol Chem 1994;269:28737-44.
30. Qiu W, Taghibiglou C, Avramoglu RK, et al. Oleate-mediated stimulation of microsomal triglyceride transfer protein (MTP) gene promoter: implications for hepatic MTP overexpression in insulin resistance. Biochemistry 2005;44:3041-9.
31. Hegele RA, Wolever TM, Story JA, Connelly PW, Jenkins DJ. Intestinal fatty acid-binding protein variation associated with variation in the response of plasma lipoproteins to dietary fibre. Eur J Clin Invest 1997;27:857-62.
32. Garcia-Garcia AB, Gonzalez C, Real JT, et al. Influence of microsomal triglyceride transfer protein promoter polymorphism -493 GT on fasting plasma triglyceride values and interaction with treatment response to atorvastatin in subjects with heterozygous familial hypercholesterolaemia. Pharmacogenet Genomics 2005;15:211-8.